Deals > All

Total search results: 10019 | Ordered by Date (descending)
1 2 3 ... 99 100 101  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
4BIO Ventures–SEVERAL: investment, 201909 first closing $50m of 4BIO Ventures II fund targeting $150m 2019-09-09
Lightcast Discovery–Instinctif Partners: public relations, 201909 service existent by Instinctif 2019-09-09
Lightcast Discovery–SEVERAL: investment, 201909 seed financing round £1.3m ($1.6m) from private investors 2019-09-09
ADC Therapeutics–SEVERAL: invvestment, 201909– IPO at NYSE filed 2019-09-06
iStar Medical–Belgium (govt): investment, 201909 financing round Series C totalling €40m incl existing + co-investor SFPI-FPIM 2019-09-05
iStar Medical–BNP Paribas: investment, 201909 financing round Series C totalling €40m incl new + co-investor BNP Paribas Fortis Private Equity 2019-09-05
iStar Medical–Capricorn Venture Partners: investment, 201909 financing round Series C totalling €40m incl existing + co-investor Capricorn 2019-09-05
iStar Medical–Earlybird: investment, 201909 financing round Series C totalling €40m incl new + co-investor Earlybird 2019-09-05
iStar Medical–Gimv: investment, 201909 financing round Series C totalling €40m incl new + co-lead investor Gimv 2019-09-05
iStar Medical–Life Sciences Partners: investment, 201909 financing round Series C totalling €40m incl new + co-lead investor LSP Health Economics 2 2019-09-05
iStar Medical–Optimum Strategic Communications: public relations, 201909 service existent by Optimum 2019-09-05
iStar Medical–SEVERAL: investment, 201905 financing round Series C €40m led by LSP + Gimv 2019-09-05
iStar Medical–Wallonia (govt): investment, 201909 financing round Series C totalling €40m incl existing + co-investor SRIW 2019-09-05
Theragnostics–AstraZeneca: PARP inhibitors, 201909– license ww freedom to operate for developm of rPARPi as cancer theragnostic 2019-09-05
Theragnostics–Optimum Strategic Communications: public relations, 201909 service existent by Optimum 2019-09-05
TreeFrog Therapeutics–EU (govt): grant, 201909– Horizon 2022 SME Instrument Program Phase 2 Grant €2.4m 2019-09-05
TreeFrog Therapeutics–France (govt): grant, 201909–2020 grant €450k from Bpifrance i-Nov Innovation Challenge Phase 2 2019-09-05
BioNTech–Gates Foundation: investment, 201909 equity investment $55m in connection with anti-infectives collaboration 2019-09-04
Curetis–OpGen: investment, 201909– reverse merger with Curetis shareholders holding 72.5% of combined entity 2019-09-04
Gates Foundation–BioNTech: anti-infectives, 201909– collab developm of HIV + TB immunotherapies with up to $100m funding incl equity investment $55m 2019-09-04
Uniqure–SEVERAL: investment, 201909– public offering $200m+$30m ANNOUNCED 2019-09-04
Achilles Therapeutics–Forbion: investment, 201909 financing round Series B totalling £100m incl new + co-investor Forbion 2019-09-03
Achilles Therapeutics–Invus Group: investment, 201909 financing round Series B totalling £100m incl new + co-investor Invus 2019-09-03
Achilles Therapeutics–Perceptive Advisors: investment, 201909 financing round Series B totalling £100m incl new + co-investor Perceptive Advisors 2019-09-03
Achilles Therapeutics–RA Capital Management: investment, 201909 financing round Series B totalling £100m incl new + lead investor RA Capital 2019-09-03
Achilles Therapeutics–Redmile Group: investment, 201909 financing round Series B totalling £100m incl new + co-investor Redmile Group 2019-09-03
Achilles Therapeutics–SEVERAL: investment, 201909 financing round Series B £100m led by RA Capital Management 2019-09-03
Achilles Therapeutics–Syncona: investment, 201909 financing round Series B totalling £100m incl existing + co-investor Syncona 2019-09-03
Univ College London–Bruker Corp: atomic force microscope, 201908 supply existent London Centre for Nanotechnology long-term user of NanoWizard systems 2019-09-02
GenomeWeb–Crain Communications: investment, 201909 acquisition of GenomeWeb LLC by Crain Communications Inc 2019-09-01
Kinomica–BioCity (GB): investment, 201908 investment by BioCity via Innovate UK Precision Medicine Investment Accelerator 2019-08-29
Celgene–Immatics: cell therapy, 201908– strategic collab + excl option $75m upfront + $1.5b milestones + royalties for three TCR-T targets 2019-08-28
HiFiBio–Delian Capital: investment, 201908 financing round Series C totalling $67m incl new + co-investor Delian Capital 2019-08-28
HiFiBio–Gilead: investment, 201908 financing round Series C totalling $67m incl new + co-investor Kite 2019-08-28
HiFiBio–Hanne Capital: investment, 201908 financing round Series C totalling $67m incl new + co-investor Hanne Capital 2019-08-28
HiFiBio–IDG Capital: investment, 201908 financing round Series C totalling $67m incl new + lead investor IDG Capital 2019-08-28
HiFiBio–Legend Star Capital: investment, 201908 financing round Series C totalling $67m incl existing + co-investor Legend Star Capital 2019-08-28
HiFiBio–Lyfe Capital: investment, 201908 financing round Series C totalling $67m incl existing + co-investor Lyfe Capital 2019-08-28
HiFiBio–Sequoia Capital: investment, 201908 financing round Series C totalling $67m incl existing + co-investor Sequoia Capital China 2019-08-28
HiFiBio–SEVERAL: investment, 201908 financing round Series C $67m led by new investor IDG Capital 2019-08-28
HiFiBio–VI Ventures: investment, 201908 financing round Series C totalling $67m incl existing + co-investor VI Ventures 2019-08-28
Protelux (RU)–Unibio: protein production from methane, 201908 collab existing buidling + operating plant for Uniprotein production in Russia 2019-08-28
Unibio–SEVERAL: investment, 201908 financing round $15m (£12.4m) from existing + new shareholders led by West Hill Capital 2019-08-28
Unibio–West Hill Capital: investment, 201908 financing round totalling $15m (£12.4m) incl lead investor West Hill Capital 2019-08-28
Adaptimmune–Noile-Immune: T cell therapy, 201908– collab up to $312m + royalties developm of SPEAR T-cell products using PRIME technology 2019-08-27
Spitality–Berlin (govt): investment, 201908 seed financing round from Capacura GmbH + VC Fonds Technologie Berlin 2019-08-27
Spitality–Capacura: investment, 201908 seed financing round from Capacura GmbH + VC Fonds Technologie Berlin 2019-08-27
Spitality–SEVERAL: investment, 201908 seed financing round from Capacura GmbH + VC Fonds Technologie Berlin to advance Krankenhaus.de 2019-08-27
Vaccitech–Scius Communications: public relations, 201908 supply service existent by Scius Communications 2019-08-27
ADC Therapeutics–Freenome: pharmacodiagnostics, 201908– collab developm multiomics biomarker for ADCT-402 treatment in DLBCL 2019-08-26
Univ Florence–Bruker Corp: NMR spectrometer, 201908– supply expected first customer for new 1.2 GHz NMR spectrometer 2019-08-26
AstraZeneca–FibroGen: roxadustat, 201908 collab existent commercialisation of roxadustat in China by AstraZeneca 2019-08-22
MDClone–aMoon: investment, 201908 financing round Series B totalling $26m incl lead investor aMoon 2019-08-22
MDClone–Lightspeed Venture Partners: investment, 201908 financing round Series B totalling $26m incl co.investor Lightspeed Venture Partners 2019-08-22
MDClone–Orbimed: investment, 201908 financing round Series B totalling $26m incl co.investor OrbiMed Israel Partners 2019-08-22
MDClone–SEVERAL: investment, 201908 financing round Series B $26m led by aMoon + incl OrbiMed + Lightspeed Venture Partners 2019-08-22
Merck (US)–Themis Bioscience: vaccine technology, 201908– collab research + license for use of MV technology platform for vaccine development 2019-08-22
Themis Bioscience–Merck (US): investment, 201908 equity investment €na by MSD as part of vaccine collaboration 2019-08-22
Oncorus–SEVERAL: investment, 201908 financing round Series B $79.5m co-led by Cowen Healthcare Investments + Perceptive Advisors 2019-08-21
Araris Biotech–Redalpine: investment, 201908 seed financing round totalling CHF2.5m incl investor Redalpine 2019-08-20
Araris Biotech–Schroders: investment, 201908 seed financing round totalling CHF2.5m incl investor Schroder Adveq 2019-08-20
Araris Biotech–SEVERAL: investment, 201908 seed financing round CHF2.5m with Redalpine + Schroder Adveq + VI Partners 2019-08-20
Araris Biotech–VI Partners: investment, 201908 seed financing round totalling CHF2.5m incl investor VI Partners 2019-08-20
Bayer–Elanco: investment, 201908– acquisition of Bayer Animal Health business for $5.3b in cash + $2.3b in shares 2019-08-20
Biotheus–Alligator Bioscience: therapeutic antibodies, 201908– license to Ab from Alligator-Gold library for bispecific molecules for Greater China 2019-08-20
Juvenescence–SEVERAL: investment, 201908 financing round Series B $100m incl founders + private investment companies 2019-08-19
AstronauTx–United Kingdom (govt): investment, 201908 investment £6.5m from Dementia Discovery Fund 2019-08-13
Synpromics–AskBio: investment, 201908 acquisition of Synpromics Ltd by Asklepios Biopharmaceutical Inc 2019-08-13
Boehringer–Univ Texas: cancer drugs, 201908– collab new virtual r+d center to advance new cancer therapies incl KRAS inhibitors + TRAILR2 agonists 2019-08-12
Cavion–Jazz Pharmaceuticals: investment, 201908 acquisition $52.5m upfront + $260m milestones of Cavion Inc by Jazz 2019-08-12
Curetis–HC Wainwright: investment banking, 201908– supply service Curetis retains HC Wainwright to evaluate all strategic options 2019-08-12
LemnaTec–Nynomic: investment, 201908 acquisition €na of assets of LemnaTec Gmbh by Nynomic AG 2019-08-12
BlueRock Therapeutics–Bayer: investment, 201808– acquisition 100% by acquiring remaining 59.2% for $240m upfront + $360m milestones 2019-08-08
a:head bio–red-stars.com data: investment, 201908– milestone-dependent 7-digit EUR seed investment by red-stars.com data AG in a:head bio AG 2019-08-07
MeiraGTx–SEVERAL: investment, 201908 public offering $75.2m+$11.28m with 3.2m+480k ordinary shares at $23.5/share 2019-08-07
Blue Heron–Eurofins: investment, 201908 acquisition of Blue Heron Biotech by Eurofins Genomics LLC 2019-08-06
BSSN Software–Merck (DE): investment, 201908 acquisition €na of BSSN Software GmbH by Merck KGaA 2019-08-06
Fosanis–Ananda Ventures: investment, 201908 milllion Euro financing round from Ananda Impact Ventures + VC Fonds Technologie Berlin 2019-08-06
Fosanis–Berlin (govt): investment, 201908 milllion Euro financing round from Ananda Impact Ventures + VC Fonds Technologie Berlin 2019-08-06
Fosanis–SEVERAL: investment, 201908 milllion Euro financing round from Ananda Impact Ventures + VC Fonds Technologie Berlin to advance mika app 2019-08-06
Merck (DE)–BSSN Software: laboratory software, 2014– supply Merck working with BSSN Software 2019-08-06
Platomics–SEVERAL: investment, 201908 investment €7-digit from undisclosed investors 2019-08-06
Cytena–Cellink: investment, 201908 acquisition €30.25m of Cytena GmbH by Cellink AB 2019-08-05
GNA Biosolutions–Bavaria (govt): investment, 201908 financing round Series C totalling $13.5m incl new investor Wachstumsfonds Bayern 2019-08-05
GNA Biosolutions–Bosch: investment, 201908 financing round Series C totalling $13.5m incl existing investor Robert Bosch Venture Capital 2019-08-05
GNA Biosolutions–btov Partners: investment, 201908 financing round Series C totalling $13.5m incl existing investor btov Partners 2019-08-05
GNA Biosolutions–Germany (govt): investment, 201908 financing round Series C totalling $13.5m incl existing investor KfW 2019-08-05
GNA Biosolutions–GreyBird Ventures: investment, 201908 financing round Series C totalling $13.5m incl new investor GreyBird Ventures 2019-08-05
GNA Biosolutions–Mey Capital Matrix: investment, 201908 financing round Series C totalling $13.5m incl existing investor Mey Capital Matrix 2019-08-05
GNA Biosolutions–Occident Group: investment, 201908 financing round Series C totalling $13.5m incl new investor Occident 2019-08-05
GNA Biosolutions–SEVERAL: investment, 201908 financing round Series C $13.5m from new + existing EU + US investors 2019-08-05
GNA Biosolutions–SHS: investment, 201908 financing round Series C totalling $13.5m incl existing investor SHS Gesellschaft für Beteiligungsmanagement 2019-08-05
GNA Biosolutions–UVC Partners: investment, 201908 financing round Series C totalling $13.5m incl existing investor UVC Partners 2019-08-05
Imcyse–Andrew Lloyd Associates: public relations, 201908 service existent by ALA 2019-08-05
Inveox–SEVERAL: investment, 201908 3rd financing round €17m 2019-08-05
Alizé Pharma–SEVERAL: investment, 201907 financing round Series A €67m of Alizé Pharma 3 led by LSP 2019-07-31
Atlantic Healthcare–Consilium: public relations, 201907 service existent European IR + media relations by CSC 2019-07-31
Atlantic Healthcare–Lazar Partners: public relations, 201907 service existent US IR + media relations by Lazar Partners 2019-07-31
Wellington Partners–Consilium: public relations, 201907 service existent by CSC 2019-07-31
Wellington Partners–EU (govt): investment, 201907 final closing totalling €210m WPLS-V fund incl exisiting investor EIB/EIF 2019-07-31
1 2 3 ... 99 100 101  next pagenext page



Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top